These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26168366)

  • 1. Mortality associated with medical therapy versus elective colectomy in ulcerative colitis: a cohort study.
    Bewtra M; Newcomb CW; Wu Q; Chen L; Xie F; Roy JA; Aarons CB; Osterman MT; Forde KA; Curtis JR; Lewis JD
    Ann Intern Med; 2015 Aug; 163(4):262-70. PubMed ID: 26168366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressant medications and mortality in inflammatory bowel disease.
    Lewis JD; Gelfand JM; Troxel AB; Forde KA; Newcomb C; Kim H; Margolis DJ; Strom BL
    Am J Gastroenterol; 2008 Jun; 103(6):1428-35; quiz 1436. PubMed ID: 18494836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality Is Rare Following Elective and Non-elective Surgery for Ulcerative Colitis, but Mild Postoperative Complications Are Common.
    Feuerstein JD; Curran T; Alosilla M; Cataldo T; Falchuk KR; Poylin V
    Dig Dis Sci; 2018 Mar; 63(3):713-722. PubMed ID: 29353444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.
    Kaplan GG; Lim A; Seow CH; Moran GW; Ghosh S; Leung Y; Debruyn J; Nguyen GC; Hubbard J; Panaccione R
    World J Gastroenterol; 2015 Jan; 21(4):1251-60. PubMed ID: 25632199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients.
    Duijvis NW; Ten Hove AS; Ponsioen CI; van den Brink GR; Buskens CJ; Bemelman WA; Te Velde AA; D'Haens GR; Löwenberg M
    J Crohns Colitis; 2016 Jul; 10(7):821-7. PubMed ID: 26818660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing colectomy rates for ulcerative colitis: a population-based time trend study.
    Kaplan GG; Seow CH; Ghosh S; Molodecky N; Rezaie A; Moran GW; Proulx MC; Hubbard J; MacLean A; Buie D; Panaccione R
    Am J Gastroenterol; 2012 Dec; 107(12):1879-87. PubMed ID: 23165448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues.
    Schmidt KJ; Müller N; Dignass A; Baumgart DC; Lehnert H; Stange EF; Herrlinger KR; Fellermann K; Büning J
    J Crohns Colitis; 2016 Jan; 10(1):31-7. PubMed ID: 26419459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
    Fernández-Salazar L; Muñoz F; Barrio J; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; Fernández N; Sánchez-Ocaña R; Joao D; Santos F
    Scand J Gastroenterol; 2016; 51(2):186-95. PubMed ID: 26200929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
    Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP
    Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of colectomy in patients with ulcerative colitis under thiopurine treatment.
    Cañas-Ventura A; Márquez L; Ricart E; Domènech E; Gisbert JP; García-Sanchez V; Marín-Jiménez I; Rodriguez-Moranta F; Gomollón F; Calvet X; Merino O; Garcia-Planella E; Vázquez-Romero N; Esteve M; Iborra M; Gutiérrez A; Vera M; Andreu M;
    J Crohns Colitis; 2014 Oct; 8(10):1287-93. PubMed ID: 24726696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elderly-Onset and Adult-Onset Ulcerative Colitis Are More Similar than Previously Reported in a Nationwide Cohort.
    Kumar V; Shah Y; Patel D; Khan N
    Dig Dis Sci; 2017 Oct; 62(10):2857-2862. PubMed ID: 28884254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study.
    Kim EH; Kim DH; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
    Gut Liver; 2015 Sep; 9(5):601-6. PubMed ID: 25473080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis.
    Murthy SK; Steinhart AH; Tinmouth J; Austin PC; Daneman N; Nguyen GC
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1032-9. PubMed ID: 23061526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids.
    Bello C; Belaiche J; Louis E; Reenaers C
    J Crohns Colitis; 2011 Jun; 5(3):196-202. PubMed ID: 21575881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to first intravenous steroid therapy determines the subsequent risk of colectomy in ulcerative colitis patients.
    Molnár T; Farkas K; Nyári T; Szepes Z; Nagy F; Wittmann T
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):359-63. PubMed ID: 22187700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis.
    Dean KE; Hikaka J; Huakau JT; Walmsley RS
    J Gastroenterol Hepatol; 2012 Mar; 27(3):487-92. PubMed ID: 22098019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics and Postoperative Complications of Patients Undergoing Emergency Surgery for Ulcerative Colitis.
    Ozawa T; Ishihara S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Kanazawa T; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
    Hepatogastroenterology; 2015 Jun; 62(140):853-8. PubMed ID: 26902015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study.
    Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1301-9. PubMed ID: 22506582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
    Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
    Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.